glp-1 news today 2025 november 6 Pipeline Update: - Prime Therapeutics Dr. Blum and our patient

Exploring weight loss options

Most patients find side effects manageable and worth the sustained weight loss benefits

adults say they have taken a GLP-1 agonist, and 6 percent are currently taking one

The Dexcom ONE Sensor is water-resistant, allowing for continued glucose monitoring during activities like showering, swimming, and exercise

Prevalence and intensity of dumping symptoms and their association with health-related quality of life following surgery for oesophageal cancer

As for mortality, both SGLT-2 inhibitors and GLP-1RA are similar in reducing both total and CV deaths, but SGLT-2 inhibitors only are superior to DPP-4 inhibitors for both deaths, whereas GLP-1RA are superior to DPP-4 inhibitors for total death, but equal for CV death